维普期刊资源整合服务平台（V6.5）

68篇 您的检索式：作者名="Heching"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Prognostic role of serum cytokeratin 19 fragments in advanced non-small cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival 显示文摘	Nisman B Biran H Heching N	2008	Br J Cancer2008，98，1：	1
2	Experiments on competition and predation among shrimps of seagrass meadows显示文摘	Coen L D Hech K L Abele L G		0，，：	1
3	Evaluation of tissue polypeptide specific antigen,CYFRA21-1 and carcinoembryonic antigen in nonsmall cell lung carcinoma;does the combined use of cytokeratin markers give any additional information显示文摘	Nisman B Lafair J Heching N	2008	Gancer2008，1582，：	1
4	Combined pricing and inventory control under uncertainty 显示文摘	FEDERGRUEN A HECHING A	1999	Operations Re- search1999，47，3：	1
5	Prognostic role of serum cytokeratin 19 fragment in advanced non-small-cell lung cancer:association of marker changes after two chemotherapy cycles with different measures of clinical response and survival显示文摘	Nisman B Biran H Heching N	2008	British Journal of Cancer2008，98，1：	1
6	Prognostic role of serum cytokeratin 19 fragment in advanced non-small- cell lung cancer:association of nmrker changes after two chemotherapy cycles with different measures of clinical response and survival 显示文摘	Nisman B Biran H Heching N	2008	Brit J Can2008，98，1：	1
7	Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer:association of marker changes after two chemotherapy cycles with different measures of clinical response and survival显示文摘	Nisman B Biran H Heching N	2008	Br J Cancer2008，98，1：	1
8	Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer:association of marker changes after two chemotherapy cycles with different measures of clinical response and survival显示文摘	Nisman B Biran H Heching N		0，，：	1
9	Safety and efficacy of intravous tissue plasminogeu activator and heparin in acute middle cerehral artery stroke显示文摘	Kummer RV Heche W	1992	Stroke1992，23，5：	1
10	Combined pricing and inventory control显示文摘	FEDERGRUEN HECHING	1999	Operations research1999，47，3：	1
11	CT-colonography:value of scanning inboththe supine and propositions显示文摘	Chen SC Lu DS Hech JR	1999	AIR1999，172，：	1
12	Combined pricing and inventory control under uncertainty显示文摘	Federgruen A Heching A	1999	Operations Research1999，47，：	1
13	Prognostic role of serum cy- tokeratin 19 fragments in advanced non-small-cell lung cancer: associ- ation of marker changes after two chemotherapy cycles with different measures of clinical response and survival显示文摘	Nisman B Biran H Heching N	2008	Br J Cancer2008，98，1：	1
14	Phase Ⅱ study with paclitaxel for treatment of advanced inoperable non-small cell lung cancer显示文摘	UIrich Gat Zeneier Mavlene Hech mayr	1998	Lung cancer1998，12，1：	1
15	A generalized quantity dis- count pricing model to increase supplier' s profits 显示文摘	Federgruen Heching M	2001	Manage- ment Science2001，36，9：	1
16	Sleep disturbances in children with multiple disabilities 显示文摘	Tietze AL Blankenburg M Hech\|er T	2012	Sleep Med Rev2012，16，2：	1
17	Phase Ⅱ studywith pacli2 taxel for treatment of advanced inoperable non-small cell lung cancer显示文摘	Uirich Gat Zeneier Mavlene Hech Mayr	1998	Lung Cancer1998，12，1：	1
18	Combining pricing and inventory control under uncertainty显示文摘	Federgruen A Heching A	1999	Operations Research1999，，47：	1
19	Combined Pricing and Inventory Control under Uncertainty显示文摘	Awi Federgruen Aliza Heching	1999	Operations Research1999，47，3：	1
20	Allicin inhibits SDF-1 alpha-induced T cell interactions with fibronectin and endothelial cells by down-regulating cytoskeleton rearrangement, Pyk-2 phosphorylation and VLA-4 expression 显示文摘	Sela U Ganor S Hech I	2004	Immunology2004，111，4：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示